Now Available: Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020

Vaginal atrophy also known as atrophic vaginitis is defined as a decrease in the production of estrogen after menopause, leading to thinning, drying, and reduced elasticity of the vaginal tissues. Up to 40% of post-menopausal women have symptoms of atrophic vaginitis. It typically affects women in the age group of 45-55 years. PVA result in symptoms such as itching, burning, dryness, and dyspareunia. Topical preparations such as hormone replacement therapy (HRT) and estrogen creams are used to treat PVA.

Technavio's analysts forecast the global PVA drugs market to grow at a CAGR of 7.13% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global PVA drugs market for 2015-2020. To calculate the market size, the report considers revenue generated from the sales of drugs (creams, tablets, patches, and rings) used to treat PVA.

Full Report Details at
- http://www.fastmr.com/prod/1154026_global_post_menopausal.aspx?afid=301

The market is divided into the following segments based on geography:

* Americas
* EMEA
* APAC

Technavio's report, Global Post-Menopausal Vaginal Atrophy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

* Pfizer Inc.
* Allergan Inc.
* Shionogi & Co. Ltd.
* Novo Nordisk A/S
* Teva Pharmaceutical Industries Ltd.

Other prominent vendors

* Bayer
* Bionovo
* EndoCeutics
* Foamix Pharmaceuticals
* Ligand Pharmaceuticals
* Pantarhei Bioscience
* Pep-Tonic Medical
* TherapeuticsMD
* Upsher-Smith Laboratories

Market driver

* Favorable healthcare reforms in the US
* For a full, detailed list, view our report

Market challenge

* Patent expiry of branded products
* For a full, detailed list, view our report

Market trend

* Paradigm shift to non-estrogenic therapies
* For a full, detailed list, view our report

Key questions answered in this report

* What will the market size be in 2020 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?
* What are the market opportunities and threats faced by the key vendors?
* What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Pfizer Inc., Allergan Inc., Shionogi & Co. Ltd., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd, Bayer, Bionovo, EndoCeutics, Foamix Pharmaceuticals, Ligand Pharmaceuticals, Pantarhei Bioscience, Pep-Tonic Medical, TherapeuticsMD, Upsher-Smith Laboratories.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)